Lumida
/SPNT
⌘K
Siriuspoint Ltd

Siriuspoint Ltd

SPNT
$24.20USD-0.66%-0.16 today

MARKET CAP

2.8B

P/E (TTM)

5.9x

FWD P/E

9.1x

DAY RANGE

$24 – $25

52W RANGE

$17
$26

AI Summary

Stalk
Buy NowMedium

SPNT remains in a Stage 2 uptrend above all key EMAs with long-term support intact. The medium-term structure is bullish, and a mild pullback into the rising 9/20/50-EMA zone offers a favorable entry. Short-term momentum is positive but RSI is slightly extended, so participation is justified on this pullback while monitoring for any downside failure of the EMAs. Long-term trend remains strong above the 200-day SMA.

  • Q2 2026 operating ROE at 14.7% with 91.4% core combined ratio
  • 23% YoY growth in accident & health lines supports revenue stability
  • Anticipated tougher market conditions in 2026 may compress underwriting margins
Full analysis →

Buying

4

institutions

Selling

4

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

SELL11.33 M271.85 M+-112.21 K+10.3%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY422.98 K10.15 M+11.70 K+14.6%0.00%
MM

Millennium Management LLC

Q2 2026

SELL305.62 K7.33 M+-146.59 K-24.7%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY150.09 K3.60 M+132.49 K+850.2%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY97.84 K2.11 M+48.92 K+97.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL40.70 K976.80 K+-189.81 K-80.3%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY1.09 K26.09 K+743.00+252.1%0.00%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

SELL0.000.00+-42.00 K-100.0%0.00%